Drug Trial Radar · NCT05411016
A Study of KK4277 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus and Cutaneous Lupus Erythematosus
Last checked: Nov 20, 2026Latest source record: Sep 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
125
Actual
Start
Aug 3, 2022
Primary completion
Dec 10, 2024
Study completion Oct 27, 2025
Sponsor
- Lead sponsor
- Kyowa Kirin Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jun 8, 2022
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Part 1 : To evaluate the safety and tolerability of a single intravenous (IV) or subcutaneous (SC) dose of KK4277 in healthy Japanese or non-Asian adult males. Part 2 : To evaluate the safety and tolerability of repeated IV or SC administration of KK4277 in patients with Systemic lupus erythematosus (SLE) or Cutaneous lupus erythematosus (CLE).
Conditions
- Healthy Volunteers
- Systemic Lupus Erythematosus (SLE)
- Cutaneous Lupus Erythematosus (CLE)
Interventions
PlaceboDrug
Placebo is administered single dose or multiple dose by IV or SC injection
KK4277Drug
KK4277 is administered single dose or multiple dose by IV or SC injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of participants with adverse events (AEs)Time frame: Part 1 : from Day 1 through at most Day 113, Part 2: from Day 1 through at most Day 169
Locations
23 sites in 2 countries. Site status is shown where the registry gives one.
Fukushima Medical University Hospital
Fukushima, Japan
Nagasaki University Hospital
Nagasaki, Japan
Juntendo University Nerima Hospital
Tokyo, Japan
Wakayama Medical University Hospital
Wakayama, Japan
Fujita Health University Hospital
Kutsukake, Aichi-ken, Japan
Japan Community Health care Organization Chukyo Hospital
Minami, Aichi-ken, Japan
Juntendo University Urayasu Hospital
Urayasu, Chiba, Japan
Kyusyu University Hospital
Higashi, Fukuoka, Japan
Kanazawa University Hospital
Kanazawa, Ishikawa-ken, Japan
Yokohama City University Medical Center
Minami, Kanagawa, Japan
Kitasato University Hospital
Minami, Kanagawa, Japan
National University Corporation Tohoku University Tohoku University Hospital
Aoba, Miyagi, Japan
Niigata University Medical & Dental Hospital
Chuo Ku, Niigata, Japan
University of the Ryukyus Hospital
Ginowan, Okinawa, Japan
Saitama Medical University Hospital
Moriyama, Saitama, Japan
Institute of Science Tokyo Hospital
Bunkyō-Ku, Tokyo, Japan
St. Luke's International Hospital
Chuo Ku, Tokyo, Japan
Showa Medical University East Hospital
Shinagawa-Ku, Tokyo, Japan
Keio University Hospital
Shinjuku-Ku, Tokyo, Japan
Japan Institute for Health Security National Center for Global Health and Medicine
Shinjuku-Ku, Tokyo, Japan
Medical Co. LTA Sumida Hospital
Sumida-ku, Tokyo, Japan
Seoul National University Hospital
Seoul, South Korea
Ajou University Hospital
Suwon, Gyeonggi-do, South Korea
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.